CUSIP: 29286M113
Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / *W EXP 10/31/202
-
Total 13F shares
-
5,502,863
-
Share change
-
+806,840
-
Total reported value
-
$28,624,959
-
Price per share
-
$5.20
-
Number of holders
-
16
-
Value change
-
+$9,669,204
-
Number of buys
-
3
-
Number of sells
-
13
Quarterly Holders Quick Answers
What is CUSIP 29286M113?
CUSIP 29286M113 identifies ENGNW - enGene Holdings Inc. - *W EXP 10/31/202 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2024
-
Previous quarter:
Q4 2023
Recent filing periods for CUSIP 29286M113:
Institutional Holders of enGene Holdings Inc. - *W EXP 10/31/202 (ENGNW) as of Q1 2024
As of 31 Mar 2024,
enGene Holdings Inc. - *W EXP 10/31/202 (ENGNW) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,502,863 shares.
The largest 10 holders included
FCPM III SERVICES B.V., BVF INC/IL, Blue Owl Capital Holdings LP, Omega Fund Management, LLC, Saba Capital Management, L.P., Calamos Advisors LLC, D. E. Shaw & Co., Inc., Polar Asset Management Partners Inc., Atalaya Capital Management LP, and TENOR CAPITAL MANAGEMENT Co., L.P..
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.